Related Experiment Video
Updated: Aug 10, 2025

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
NKG2A blocks the anti-metastatic functions of natural killer cells
Florent Carrette1, Eric Vivier2
1Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC)-derived liver metastasis represents a major unmet medical need. Liu et al. show that circulating tumor cells (CTCs) from the hepatic portal vein (HPV), and not from primary or metastatic sites, are protected from natural killer (NK) cells through the NKG2A/HLA-E axis. Interfering with this pathway unleashes NK cells and prevents PDAC metastasis.
Insights
Pancreatic cancer liver metastasis is a major challenge. Researchers found that circulating tumor cells in the hepatic portal vein evade natural killer cells via the NKG2A/HLA-E pathway, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Immunology
- Cancer Metastasis
Background:
- Pancreatic ductal adenocarcinoma (PDAC) liver metastasis poses a significant clinical challenge.
- Understanding the mechanisms of immune evasion by circulating tumor cells (CTCs) is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the immune evasion mechanisms of PDAC-derived CTCs in the hepatic portal vein (HPV).
- To identify the specific molecular pathways involved in protecting CTCs from natural killer (NK) cell-mediated lysis.
Main Methods:
- Analysis of CTCs isolated from the HPV of PDAC patients.
- Assessment of NK cell cytotoxicity against CTCs.
- Investigation of the role of the NKG2A/HLA-E axis in immune evasion.
Main Results:
- PDAC-derived CTCs in the HPV, but not from primary or other metastatic sites, are protected from NK cell attack.
- This protection is mediated by the interaction between NKG2A on NK cells and HLA-E expressed by CTCs.
- Blocking the NKG2A/HLA-E pathway restores NK cell-mediated killing of CTCs.
Conclusions:
- The NKG2A/HLA-E axis is a key mechanism for PDAC CTC immune evasion in the liver.
- Targeting this pathway represents a promising therapeutic strategy to prevent or treat PDAC liver metastasis.
More Related Videos
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

